{
  "timestamp": "20250102_232018",
  "model": "gpt-3.5-turbo",
  "interaction_type": "direct_answer",
  "question_id": "4a02a891",
  "question_text": "Which of the following does not cause Insulin release-",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\nQuestion: Which of the following does not cause Insulin release-\n\nOptions:\nopa. Rosiglitazone\nopb. Nateglinide\nopc. Glimipiride\nopd. Tobutamide\n\n        ### Output Format\n        Provide your response in valid JSON format:\n        {   \n            \"final_analysis\": \"Your concise analysis following the above structure\",\n            \"answer\": \"Option key from the available options (only key,like opa)\",\n            \"confidence\": Score between 0-100 based on alignment with established medical facts\n        }\n        "
    }
  ],
  "response": "{\n    \"final_analysis\": \"Insulin release is primarily stimulated by glucose levels in the blood. Among the options provided, Rosiglitazone is a thiazolidinedione which works by increasing insulin sensitivity in peripheral tissues but does not directly cause insulin release.\",\n    \"answer\": \"opa\",\n    \"confidence\": 95\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": false,
    "has_enhanced_info": false,
    "model_config": "gpt-3.5-turbo",
    "temperature": 0.0
  }
}